CORTEF

This brand name is authorized in Canada, Hong Kong, Croatia, Lithuania, Tunisia, United States

Active ingredients

The drug CORTEF contains one active pharmaceutical ingredient (API):

1 Hydrocortisone UNII WI4X0X7BPJ - HYDROCORTISONE

Hydrocortisone is the main glucocorticoid secreted by the adrenal cortex. Hydrocortisone is an anti-inflammatory steroid. Its anti-inflammatory action is due to reduction in the vascular component of the inflammatory response and reduction in the formation of inflammatory fluid and cellular exudates. Read about Hydrocortisone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CORTEF Tablet	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H02AB09	Hydrocortisone	H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AB Glucocorticoids
Discover more medicines within H02AB09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 00030910, 00030929
Country: HK	Department of Health Drug Office	Identifier(s): 37278
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-281556040
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1088947
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 10763011
Country: US	FDA, National Drug Code	Identifier(s): 0009-0012, 0009-0031, 0009-0044